HER2 Support Group Forums - View Single Post - Perjeta® (pertuzumab) first treatment for advanced breast cancer to extend surviv

News · 09-29-2014, 04:00 AM

Perjeta, in combination with Herceptin® (trastuzumab) and chemotherapy (docetaxel), can extend survival in women with previously untreated, advanced HER2-positive breast cancer to over four and...

More...

09-29-2014, 04:00 AM	#1
News Senior Member Join Date: Oct 2007 Posts: 20,107	Perjeta® (pertuzumab) first treatment for advanced breast cancer to extend surviv Perjeta, in combination with Herceptin® (trastuzumab) and chemotherapy (docetaxel), can extend survival in women with previously untreated, advanced HER2-positive breast cancer to over four and... More...